Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsActive Not Recruiting
NCT02496208Phase 1Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Bladder Small Cell Neuroendocrine Carcinoma · Bladder Squamous Cell Carcinoma · Bladder Urothelial Carcinoma · Clear Cell Renal Cell Carcinoma
United States
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast CancerActive Not Recruiting
NCT05852691Phase 2Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Brazil, Czechia +11 more
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruiting
NCT05564377Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Malignant Solid Neoplasm
United States, Puerto Rico
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLERecruiting
NCT06897930Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: AstraZeneca
Lupus Erythematosus, Systemic
United States, Australia, Canada, United Kingdom
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideCompleted
NCT00632853Phase 3Updated Sep 10, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Lung Cancer
United States, Israel, Puerto Rico, South Korea
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut SyndromeCompleted
NCT04938427Phase 3Updated Sep 10, 2026
Sponsor: Takeda
Lennox Gastaut Syndrome (LGS)
United States, Australia, Belgium, Canada, China +13 more
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaRecruiting
NCT07592273Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: AbbVie
Diabetic Retinopathy
United States, Puerto Rico
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDSTerminated
NCT06704152Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: BlueSphere Bio, Inc
AML, Adult Recurrent · ALL, Recurrent, Adult · MDS
United States
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryRecruiting
NCT03180268Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Grade 2 Meningioma · Intracranial Meningioma
United States, Canada, India, Japan, Saudi Arabia
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruiting
NCT05997615Phase 1Updated Sep 10, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Hormone-refractory Prostate Cancer
United States, Australia, Spain, United Kingdom
A Phase 1/2 Trial of ADI-212 in mCRPCNot Yet Recruiting
NCT07793435Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Adicet Therapeutics
Prostate Cancer Metastatic
United States
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruiting
NCT05675410Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
United States, Canada, Puerto Rico
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruiting
NCT07504458Phase 3Updated Sep 10, 2026
Sponsor: Quetzal Therapeutics
Acute Promyelocytic Leukemia (APL) · Acute Promyelocytic Leukaemia · Acute Promyelocytic Leukemia With PML-RARA · Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
United States, France, Romania, Spain
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Recruiting
NCT06317649Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia
United States, Puerto Rico
ELUCIDATE FFRct StudyCompleted
NCT06018194N/AUpdated Sep 10, 2026
Sponsor: Elucid Bioimaging Inc.
Coronary Artery Disease
United States
Impact of Sinus Surgery on Individuals With Cystic FibrosisRecruiting
NCT04469439N/AUpdated Sep 10, 2026
Sponsor: University of California, Los Angeles
Chronic Rhinosinusitis (Diagnosis) · Cystic Fibrosis
United States
Teaching Doctors in Training to Reason With Artificial IntelligenceNot Yet Recruiting
NCT07813754NAUpdated Sep 10, 2026
Sponsor: Beth Israel Deaconess Medical Center
Artificial Intelligence (AI) · Clinical Reasoning · Clinical Decision-making · Medical Education
United States
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN LossTerminated
NCT04251533Phase 3Updated Sep 10, 2026
Sponsor: Novartis Pharmaceuticals
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Austria, Brazil +25 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruiting
NCT06498635Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
A Phase 1/2 Trial of ADI-270 in ccRCCActive Not Recruiting
NCT06480565Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Adicet Therapeutics
Clear Cell Renal Cell Carcinoma
United States
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerActive Not Recruiting
NCT02101775Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Ovarian Brenner Tumor · Ovarian Clear Cell Cystadenocarcinoma · Ovarian Endometrioid Adenocarcinoma · Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor
United States, Canada, Singapore
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompleted
NCT06797869Phase 2Updated Sep 10, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2 · Diabetic Peripheral Neuropathy
United States, Canada, Denmark, France, Norway +2 more
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsRecruiting
NCT06914128Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Bayer
MTAP-deleted Solid Tumors
United States, Australia, Belgium, China, Czechia +8 more
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerActive Not Recruiting
NCT01142388Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Esophageal Adenocarcinoma · Metastatic Esophageal Squamous Cell Carcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Recurrent Esophageal Adenocarcinoma
United States
A Study of Mosliciguat in PH-ILDActive Not Recruiting
NCT06635850Phase 2Updated Sep 10, 2026
Sponsor: Pulmovant, Inc.
Pulmonary Hypertension · Interstitial Lung Disease · Lung Diseases · Vascular Diseases
United States, Argentina, Australia, Belgium, Brazil +15 more

Previous page Next page